Adare Pharma encourages pediatric medications; Australian researchers developing better hydrogels;

> Adare Pharmaceuticals and Cincinnati Children's Hospital Medical Center said they are teaming up to create an Innovation Fund to optimized and reformulate medicines for children by making them easier to administer, for example. More

> Researchers at Australia's University of Wollongong are developing heat-sensitive hydrogel that contains boron nitride. "The effectiveness of these applications is highly dependent on the hydrogel's response to changes in temperature. In most cases it needs to be very fast. The problem is that the heat does not spread rapidly through the gel," lead researcher Dr. Zhenguo Huang said. More

Suggested Articles

Genentech's Port Delivery System with ranibizumab matched Lucentis eye injections in a late-stage, wet age-related macular degeneration trial.

Honeywell aims to wean the industry of its glass habit with Aclar Edge, a new line of bottles and vials made with the company's patented plastic.

Astex's oral reformulation of a common chemo combo looks to replace lengthy infusions with a once-daily tablet that patients can take at home.